Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning vs Evening Valsartan in Healthy Adults
NCT02631031Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of valsartan in hypertension (HTN), sponsored by Ain Shams University. Primary endpoint: Pharmacokinetic parameters at 48 hours. Started Nov 2015; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02631031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631031.